|Table of Contents|

Sodium arsenite combined with tetrandrine inhibits the proliferation of MDA-MB-231 cells in breast cancer and its mechanism

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2019 04
Page:
546-551
Research Field:
Publishing date:

Info

Title:
Sodium arsenite combined with tetrandrine inhibits the proliferation of MDA-MB-231 cells in breast cancer and its mechanism
Author(s):
Yu Bowen12Fan Yingyi2Guo Yubo12Pei Xiaohua3
1.Beijing University of Chinese Medicine,Beijing 100029,China;2.Galactophore Department,Beijing University of Chinese Medicine Third Affiliated Hospital,Beijing 100029,China;3.Fangshan Tradition Medical Hospital of Beijing,Beijing 102488,China.
Keywords:
breast cancersodium arsenitetetrandrineproliferation inhibitionapoptosis
PACS:
R737.9
DOI:
10.3969/j.issn.1672-4992.2019.04.002
Abstract:
Objective:To investigate the effects of sodium arsenite combined with tetrandrine on proliferation inhibition in human breast cancer cell line MDA-MB-231.Methods:Cell proliferation was measured using MTT assay.Cell apoptosis was examined by Annexin V-FITC/PI double staining analysis.Chromatin condensation was observed by Hoechst33258 staining.Cell cycle was examined by PI staining.The expression of p-GSK3β,GSK3β and apoptosis-related proteins PARP,bcl-2 were detected by Western blot.Results:Both alone sodium arsenite and alone tetrandrine could inhibit the proliferation of MDA-MB-231 cells (P<0.01).Compared with each drug alone,the combination could enhance the inhibition rate (P<0.000 1).Apoptosis was induced significantly by the combination.Chromatin condensation was observed,and the apoptosis rate was dose-dependent.After treatment with NaAsO2 10 μmol/L+tetrandrine 4 μg/ml for 48 h,the rate of S phase was increased significantly (P<0.05).After treatment with NaAsO2 15 μmol/L+tetrandrine 4.5 μg/ml for 48 h,the rate of G2/M phase was increased significantly (P<0.001).After treatment with the combination,the expression levels of PARP,p-GSK3β,GSK3β were up-regulated (P<0.000 1),while bcl-2 was down-regulated (P<0.05).Conclusion:Sodium arsenite combined with tetrandrine could inhibit the proliferation of MDA-MB-231 cells.The mechanism was related to cell cycle S phase or G2/M phase arrest,the up-regulation of GSK3β protein,and apoptosis induction.

References:

[1] Qiu LQ,Abey S,Harris S,et al.Global analysis of posttranscriptional gene expression in response to sodium arsenite[J].Environ Health Perspect,2015,123(4):324-330.
[2] Adil M,Kandhare AD,Visnagri A,et al.Naringin ameliorates sodium arsenite-induced renal and hepatic toxicity in rats:Decisive role of KIM-1,Caspase-3,TGF-β,and TNF-α[J].Ren Fail,2015,37(8):1396-1407.
[3] Li Y,Wu J,Zheng YJ,et al.Effects of sodium arsenite on skinkeratinocytes related gene expression[J].J Xinjiang Med Univ,2016,39(2):164-168.[李煜,吴军,郑玉建,等.亚砷酸钠对皮肤细胞角化相关基因表达的影响[J].新疆医科大学学报,2016,39(2):164-168.]
[4] Zhang TJ,Guo RX,Li X,et al.Tetrandrine cardioprotection in ischemia-reperfusion (I/R) injury via JAK3/STAT3/Hexokinase II[J].Eur J Pharmacol,2017,813:153-160.
[5] Wu XL,Li JX,Li ZD,et al.Protective effect of tetrandrine on sodium taurocholate-induced severe acute pancreatitis[J].Evid Based Complementary and Alternat Med,2015,2015:129103.
[6] Liu T,Liu X,Li W.Tetrandrine,a Chinese plant-derived alkaloid,is a potential candidate for cancer chemotherapy[J].Oncotarget,2016,7(26):40800-40815.
[7] Hong-Duck Um.Bcl-2 family proteins as regulators of cancer cell invasion and metastasis:A review focusing on mitochondrial respiration and reactive oxygen species[J].Oncotarget,2016,7(5):5193-5203.
[8] Senkevitch E,Li W,Hixon JA,et al.Inhibiting Janus Kinase 1 and BCL-2 to treat T cell acute lymphoblastic leukemia with IL7-Rα mutations[J].Oncotarget,2018,9(32):22605-22617.
[9] Syed O Ali,Farhaan A Khan,Miguel A Galindo-Campos,et al.Understanding specific functions of PARP-2:New lessons for cancer therapy[J].Am J Cancer Res,2016,6(9):1842-1863.
[10] Natalia Bailon-Moscoso,Gabriela Cevallos-Solorzano,Juan Carlos Romero-Benavides,et al.Natural compounds as modulators of cell cycle arrest:Application for anticancer chemotherapies[J].Curr Genomics,2017,18(2):106-131.
[11] S Phukan,VS Babu,A Kannoji,et al.GSK3β:Role in therapeutic landscape and development of modulators[J].Br J Pharmacol,2010,160(1):1-19.
[12] Wu F,Chen J,Fan LM.Analysis of the effect of rutin on GSK-3β and TNF-α expression in lung cancer[J].Exp Ther Med,2017,14(1):127-130.

Memo

Memo:
National Natural Science Foundation of China(No.81560775);国家自然科学基金(编号:81560775);北京市自然科学基金(编号:7182098)
Last Update: 1900-01-01